Click for best price
Human Embryonic Stem Cells HESC Market Size, Share 2022
Market Analysis and Insights: Global Human Embryonic Stem Cells HESC Market
The global Human Embryonic Stem Cells HESC market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Embryonic Stem Cells HESC market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Embryonic Stem Cells HESC market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Embryonic Stem Cells HESC market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Embryonic Stem Cells HESC market.
Global Human Embryonic Stem Cells HESC Scope and Market Size
Human Embryonic Stem Cells (HESC) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Human Embryonic Stem Cells (HESC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Human Embryonic Stem Cells (HESC) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Totipotent Stem Cells
Pluripotent Stem Cells
Unipotent Stem Cells
Segment by Application
Research
Clinical Trials
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
ESI BIO
Thermo Fisher
BioTime
MilliporeSigma (Merck)
BD Biosciences
Astellas Institute of Regenerative Medicine
Asterias Biotherapeutics
PerkinElmer
Takara Bio
Fujifilm Cellular Dynamics
Reliance Life Sciences
R&D Systems (Biotrchne)
STEMCELL Technologies
TATAA Biocenter
UK Stem Cell Bank
Viacyte, Inc.
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Human Embryonic Stem Cells HESC product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Human Embryonic Stem Cells HESC, with price, sales, revenue, and global market share of Human Embryonic Stem Cells HESC from 2019 to 2022.
Chapter 3, the Human Embryonic Stem Cells HESC competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Embryonic Stem Cells HESC breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Human Embryonic Stem Cells HESC market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Embryonic Stem Cells HESC.
Chapter 13, 14, and 15, to describe Human Embryonic Stem Cells HESC sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Human Embryonic Stem Cells HESC Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Human Embryonic Stem Cells (HESC) Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Human Embryonic Stem Cells (HESC) Product Introduction
1.2 Global Human Embryonic Stem Cells (HESC) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Human Embryonic Stem Cells (HESC) Sales in US$ Million for the Year 2017-2028
1.2.2 Global Human Embryonic Stem Cells (HESC) Sales in Volume for the Year 2017-2028
1.3 United States Human Embryonic Stem Cells (HESC) Outlook 2017 VS 2022 VS 2028
1.3.1 United States Human Embryonic Stem Cells (HESC) Sales in US$ Million for the Year 2017-2028
1.3.2 United States Human Embryonic Stem Cells (HESC) Sales in Volume for the Year 2017-2028
1.4 Human Embryonic Stem Cells (HESC) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Human Embryonic Stem Cells (HESC) in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Human Embryonic Stem Cells (HESC) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Human Embryonic Stem Cells (HESC) Market Dynamics
1.5.1 Human Embryonic Stem Cells (HESC) Industry Trends
1.5.2 Human Embryonic Stem Cells (HESC) Market Drivers
1.5.3 Human Embryonic Stem Cells (HESC) Market Challenges
1.5.4 Human Embryonic Stem Cells (HESC) Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Human Embryonic Stem Cells (HESC) Market Segment by Type
2.1.1 Totipotent Stem Cells
2.1.2 Pluripotent Stem Cells
2.1.3 Unipotent Stem Cells
2.2 Global Human Embryonic Stem Cells (HESC) Market Size by Type
2.2.1 Global Human Embryonic Stem Cells (HESC) Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Human Embryonic Stem Cells (HESC) Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Human Embryonic Stem Cells (HESC) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Human Embryonic Stem Cells (HESC) Market Size by Type
2.3.1 United States Human Embryonic Stem Cells (HESC) Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Human Embryonic Stem Cells (HESC) Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Human Embryonic Stem Cells (HESC) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Human Embryonic Stem Cells (HESC) Market Segment by Application
3.1.1 Research
3.1.2 Clinical Trials
3.1.3 Others
3.2 Global Human Embryonic Stem Cells (HESC) Market Size by Application
3.2.1 Global Human Embryonic Stem Cells (HESC) Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Human Embryonic Stem Cells (HESC) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Human Embryonic Stem Cells (HESC) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Human Embryonic Stem Cells (HESC) Market Size by Application
3.3.1 United States Human Embryonic Stem Cells (HESC) Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Human Embryonic Stem Cells (HESC) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Human Embryonic Stem Cells (HESC) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Human Embryonic Stem Cells (HESC) Competitor Landscape by Company
4.1 Global Human Embryonic Stem Cells (HESC) Market Size by Company
4.1.1 Top Global Human Embryonic Stem Cells (HESC) Manufacturers Ranked by Revenue (2021)
4.1.2 Global Human Embryonic Stem Cells (HESC) Revenue by Manufacturer (2017-2022)
4.1.3 Global Human Embryonic Stem Cells (HESC) Sales by Manufacturer (2017-2022)
4.1.4 Global Human Embryonic Stem Cells (HESC) Price by Manufacturer (2017-2022)
4.2 Global Human Embryonic Stem Cells (HESC) Concentration Ratio (CR)
4.2.1 Human Embryonic Stem Cells (HESC) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Embryonic Stem Cells (HESC) in 2021
4.2.3 Global Human Embryonic Stem Cells (HESC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Human Embryonic Stem Cells (HESC) Manufacturing Base Distribution, Product Type
4.3.1 Global Human Embryonic Stem Cells (HESC) Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Human Embryonic Stem Cells (HESC) Product Type
4.3.3 Date of International Manufacturers Enter into Human Embryonic Stem Cells (HESC) Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Human Embryonic Stem Cells (HESC) Market Size by Company
4.5.1 Top Human Embryonic Stem Cells (HESC) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Human Embryonic Stem Cells (HESC) Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Human Embryonic Stem Cells (HESC) Sales by Players (2020, 2021 & 2022)
5 Global Human Embryonic Stem Cells (HESC) Market Size by Region
5.1 Global Human Embryonic Stem Cells (HESC) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Human Embryonic Stem Cells (HESC) Market Size in Volume by Region (2017-2028)
5.2.1 Global Human Embryonic Stem Cells (HESC) Sales in Volume by Region: 2017-2022
5.2.2 Global Human Embryonic Stem Cells (HESC) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Human Embryonic Stem Cells (HESC) Market Size in Value by Region (2017-2028)
5.3.1 Global Human Embryonic Stem Cells (HESC) Sales in Value by Region: 2017-2022
5.3.2 Global Human Embryonic Stem Cells (HESC) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Human Embryonic Stem Cells (HESC) Market Size YoY Growth 2017-2028
6.1.2 North America Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Human Embryonic Stem Cells (HESC) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Human Embryonic Stem Cells (HESC) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Human Embryonic Stem Cells (HESC) Market Size YoY Growth 2017-2028
6.3.2 Europe Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Human Embryonic Stem Cells (HESC) Market Size YoY Growth 2017-2028
6.4.2 Latin America Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 ESI BIO
7.1.1 ESI BIO Corporation Information
7.1.2 ESI BIO Description and Business Overview
7.1.3 ESI BIO Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.1.4 ESI BIO Human Embryonic Stem Cells (HESC) Products Offered
7.1.5 ESI BIO Recent Development
7.2 Thermo Fisher
7.2.1 Thermo Fisher Corporation Information
7.2.2 Thermo Fisher Description and Business Overview
7.2.3 Thermo Fisher Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Thermo Fisher Human Embryonic Stem Cells (HESC) Products Offered
7.2.5 Thermo Fisher Recent Development
7.3 BioTime
7.3.1 BioTime Corporation Information
7.3.2 BioTime Description and Business Overview
7.3.3 BioTime Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.3.4 BioTime Human Embryonic Stem Cells (HESC) Products Offered
7.3.5 BioTime Recent Development
7.4 MilliporeSigma (Merck)
7.4.1 MilliporeSigma (Merck) Corporation Information
7.4.2 MilliporeSigma (Merck) Description and Business Overview
7.4.3 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.4.4 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Products Offered
7.4.5 MilliporeSigma (Merck) Recent Development
7.5 BD Biosciences
7.5.1 BD Biosciences Corporation Information
7.5.2 BD Biosciences Description and Business Overview
7.5.3 BD Biosciences Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.5.4 BD Biosciences Human Embryonic Stem Cells (HESC) Products Offered
7.5.5 BD Biosciences Recent Development
7.6 Astellas Institute of Regenerative Medicine
7.6.1 Astellas Institute of Regenerative Medicine Corporation Information
7.6.2 Astellas Institute of Regenerative Medicine Description and Business Overview
7.6.3 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Products Offered
7.6.5 Astellas Institute of Regenerative Medicine Recent Development
7.7 Asterias Biotherapeutics
7.7.1 Asterias Biotherapeutics Corporation Information
7.7.2 Asterias Biotherapeutics Description and Business Overview
7.7.3 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Products Offered
7.7.5 Asterias Biotherapeutics Recent Development
7.8 PerkinElmer
7.8.1 PerkinElmer Corporation Information
7.8.2 PerkinElmer Description and Business Overview
7.8.3 PerkinElmer Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.8.4 PerkinElmer Human Embryonic Stem Cells (HESC) Products Offered
7.8.5 PerkinElmer Recent Development
7.9 Takara Bio
7.9.1 Takara Bio Corporation Information
7.9.2 Takara Bio Description and Business Overview
7.9.3 Takara Bio Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Takara Bio Human Embryonic Stem Cells (HESC) Products Offered
7.9.5 Takara Bio Recent Development
7.10 Fujifilm Cellular Dynamics
7.10.1 Fujifilm Cellular Dynamics Corporation Information
7.10.2 Fujifilm Cellular Dynamics Description and Business Overview
7.10.3 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Products Offered
7.10.5 Fujifilm Cellular Dynamics Recent Development
7.11 Reliance Life Sciences
7.11.1 Reliance Life Sciences Corporation Information
7.11.2 Reliance Life Sciences Description and Business Overview
7.11.3 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Products Offered
7.11.5 Reliance Life Sciences Recent Development
7.12 R&D Systems (Biotrchne)
7.12.1 R&D Systems (Biotrchne) Corporation Information
7.12.2 R&D Systems (Biotrchne) Description and Business Overview
7.12.3 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.12.4 R&D Systems (Biotrchne) Products Offered
7.12.5 R&D Systems (Biotrchne) Recent Development
7.13 STEMCELL Technologies
7.13.1 STEMCELL Technologies Corporation Information
7.13.2 STEMCELL Technologies Description and Business Overview
7.13.3 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.13.4 STEMCELL Technologies Products Offered
7.13.5 STEMCELL Technologies Recent Development
7.14 TATAA Biocenter
7.14.1 TATAA Biocenter Corporation Information
7.14.2 TATAA Biocenter Description and Business Overview
7.14.3 TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.14.4 TATAA Biocenter Products Offered
7.14.5 TATAA Biocenter Recent Development
7.15 UK Stem Cell Bank
7.15.1 UK Stem Cell Bank Corporation Information
7.15.2 UK Stem Cell Bank Description and Business Overview
7.15.3 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.15.4 UK Stem Cell Bank Products Offered
7.15.5 UK Stem Cell Bank Recent Development
7.16 Viacyte, Inc.
7.16.1 Viacyte, Inc. Corporation Information
7.16.2 Viacyte, Inc. Description and Business Overview
7.16.3 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Viacyte, Inc. Products Offered
7.16.5 Viacyte, Inc. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Human Embryonic Stem Cells (HESC) Industry Chain Analysis
8.2 Human Embryonic Stem Cells (HESC) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Human Embryonic Stem Cells (HESC) Distributors
8.3 Human Embryonic Stem Cells (HESC) Production Mode & Process
8.4 Human Embryonic Stem Cells (HESC) Sales and Marketing
8.4.1 Human Embryonic Stem Cells (HESC) Sales Channels
8.4.2 Human Embryonic Stem Cells (HESC) Distributors
8.5 Human Embryonic Stem Cells (HESC) Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Human Embryonic Stem Cells (HESC) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Human Embryonic Stem Cells (HESC) Market Trends
Table 3. Human Embryonic Stem Cells (HESC) Market Drivers
Table 4. Human Embryonic Stem Cells (HESC) Market Challenges
Table 5. Human Embryonic Stem Cells (HESC) Market Restraints
Table 6. Global Human Embryonic Stem Cells (HESC) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Human Embryonic Stem Cells (HESC) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Human Embryonic Stem Cells (HESC) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Human Embryonic Stem Cells (HESC) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Human Embryonic Stem Cells (HESC) Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Human Embryonic Stem Cells (HESC) Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Human Embryonic Stem Cells (HESC) Revenue Share by Manufacturer, 2017-2022
Table 13. Global Human Embryonic Stem Cells (HESC) Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Human Embryonic Stem Cells (HESC) Sales Share by Manufacturer, 2017-2022
Table 15. Global Human Embryonic Stem Cells (HESC) Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Human Embryonic Stem Cells (HESC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Human Embryonic Stem Cells (HESC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Embryonic Stem Cells (HESC) as of 2021)
Table 18. Top Players of Human Embryonic Stem Cells (HESC) in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Human Embryonic Stem Cells (HESC) Product Type
Table 20. Date of International Manufacturers Enter into Human Embryonic Stem Cells (HESC) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Human Embryonic Stem Cells (HESC) Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Human Embryonic Stem Cells (HESC) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Human Embryonic Stem Cells (HESC) Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Human Embryonic Stem Cells (HESC) Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Human Embryonic Stem Cells (HESC) Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Human Embryonic Stem Cells (HESC) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Human Embryonic Stem Cells (HESC) Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Human Embryonic Stem Cells (HESC) Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Human Embryonic Stem Cells (HESC) Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Human Embryonic Stem Cells (HESC) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Human Embryonic Stem Cells (HESC) Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Human Embryonic Stem Cells (HESC) Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Human Embryonic Stem Cells (HESC) Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Human Embryonic Stem Cells (HESC) Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Human Embryonic Stem Cells (HESC) Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Human Embryonic Stem Cells (HESC) Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Human Embryonic Stem Cells (HESC) Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Human Embryonic Stem Cells (HESC) Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Human Embryonic Stem Cells (HESC) Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Human Embryonic Stem Cells (HESC) Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. ESI BIO Corporation Information
Table 43. ESI BIO Description and Business Overview
Table 44. ESI BIO Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. ESI BIO Human Embryonic Stem Cells (HESC) Product
Table 46. ESI BIO Recent Development
Table 47. Thermo Fisher Corporation Information
Table 48. Thermo Fisher Description and Business Overview
Table 49. Thermo Fisher Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Thermo Fisher Product
Table 51. Thermo Fisher Recent Development
Table 52. BioTime Corporation Information
Table 53. BioTime Description and Business Overview
Table 54. BioTime Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. BioTime Product
Table 56. BioTime Recent Development
Table 57. MilliporeSigma (Merck) Corporation Information
Table 58. MilliporeSigma (Merck) Description and Business Overview
Table 59. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. MilliporeSigma (Merck) Product
Table 61. MilliporeSigma (Merck) Recent Development
Table 62. BD Biosciences Corporation Information
Table 63. BD Biosciences Description and Business Overview
Table 64. BD Biosciences Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. BD Biosciences Product
Table 66. BD Biosciences Recent Development
Table 67. Astellas Institute of Regenerative Medicine Corporation Information
Table 68. Astellas Institute of Regenerative Medicine Description and Business Overview
Table 69. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Astellas Institute of Regenerative Medicine Product
Table 71. Astellas Institute of Regenerative Medicine Recent Development
Table 72. Asterias Biotherapeutics Corporation Information
Table 73. Asterias Biotherapeutics Description and Business Overview
Table 74. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Asterias Biotherapeutics Product
Table 76. Asterias Biotherapeutics Recent Development
Table 77. PerkinElmer Corporation Information
Table 78. PerkinElmer Description and Business Overview
Table 79. PerkinElmer Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. PerkinElmer Product
Table 81. PerkinElmer Recent Development
Table 82. Takara Bio Corporation Information
Table 83. Takara Bio Description and Business Overview
Table 84. Takara Bio Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Takara Bio Product
Table 86. Takara Bio Recent Development
Table 87. Fujifilm Cellular Dynamics Corporation Information
Table 88. Fujifilm Cellular Dynamics Description and Business Overview
Table 89. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Fujifilm Cellular Dynamics Product
Table 91. Fujifilm Cellular Dynamics Recent Development
Table 92. Reliance Life Sciences Corporation Information
Table 93. Reliance Life Sciences Description and Business Overview
Table 94. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Reliance Life Sciences Product
Table 96. Reliance Life Sciences Recent Development
Table 97. R&D Systems (Biotrchne) Corporation Information
Table 98. R&D Systems (Biotrchne) Description and Business Overview
Table 99. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. R&D Systems (Biotrchne) Product
Table 101. R&D Systems (Biotrchne) Recent Development
Table 102. STEMCELL Technologies Corporation Information
Table 103. STEMCELL Technologies Description and Business Overview
Table 104. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. STEMCELL Technologies Product
Table 106. STEMCELL Technologies Recent Development
Table 107. TATAA Biocenter Corporation Information
Table 108. TATAA Biocenter Description and Business Overview
Table 109. TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. TATAA Biocenter Product
Table 111. TATAA Biocenter Recent Development
Table 112. UK Stem Cell Bank Corporation Information
Table 113. UK Stem Cell Bank Description and Business Overview
Table 114. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. UK Stem Cell Bank Product
Table 116. UK Stem Cell Bank Recent Development
Table 117. Viacyte, Inc. Corporation Information
Table 118. Viacyte, Inc. Description and Business Overview
Table 119. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Viacyte, Inc. Product
Table 121. Viacyte, Inc. Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Human Embryonic Stem Cells (HESC) Customers List
Table 125. Human Embryonic Stem Cells (HESC) Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Embryonic Stem Cells (HESC) Product Picture
Figure 2. Global Human Embryonic Stem Cells (HESC) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Human Embryonic Stem Cells (HESC) Market Size 2017-2028 (US$ Million)
Figure 4. Global Human Embryonic Stem Cells (HESC) Sales 2017-2028 (K Units)
Figure 5. United States Human Embryonic Stem Cells (HESC) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Human Embryonic Stem Cells (HESC) Market Size 2017-2028 (US$ Million)
Figure 7. United States Human Embryonic Stem Cells (HESC) Sales 2017-2028 (K Units)
Figure 8. United States Human Embryonic Stem Cells (HESC) Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Human Embryonic Stem Cells (HESC) Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Human Embryonic Stem Cells (HESC) Report Years Considered
Figure 11. Product Picture of Totipotent Stem Cells
Figure 12. Product Picture of Pluripotent Stem Cells
Figure 13. Product Picture of Unipotent Stem Cells
Figure 14. Global Human Embryonic Stem Cells (HESC) Market Share by Type in 2022 & 2028
Figure 15. Global Human Embryonic Stem Cells (HESC) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Human Embryonic Stem Cells (HESC) Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Human Embryonic Stem Cells (HESC) Sales by Type (2017-2028) & (K Units)
Figure 18. Global Human Embryonic Stem Cells (HESC) Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Human Embryonic Stem Cells (HESC) Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Human Embryonic Stem Cells (HESC) Market Share by Type in 2022 & 2028
Figure 21. United States Human Embryonic Stem Cells (HESC) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Human Embryonic Stem Cells (HESC) Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Human Embryonic Stem Cells (HESC) Sales by Type (2017-2028) & (K Units)
Figure 24. United States Human Embryonic Stem Cells (HESC) Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Human Embryonic Stem Cells (HESC) Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Research
Figure 27. Product Picture of Clinical Trials
Figure 28. Product Picture of Others
Figure 29. Global Human Embryonic Stem Cells (HESC) Market Share by Application in 2022 & 2028
Figure 30. Global Human Embryonic Stem Cells (HESC) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Human Embryonic Stem Cells (HESC) Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Human Embryonic Stem Cells (HESC) Sales by Application (2017-2028) & (K Units)
Figure 33. Global Human Embryonic Stem Cells (HESC) Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Human Embryonic Stem Cells (HESC) Price by Application (2017-2028) & (USD/Unit)
Figure 35. United States Human Embryonic Stem Cells (HESC) Market Share by Application in 2022 & 2028
Figure 36. United States Human Embryonic Stem Cells (HESC) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Human Embryonic Stem Cells (HESC) Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Human Embryonic Stem Cells (HESC) Sales by Application (2017-2028) & (K Units)
Figure 39. United States Human Embryonic Stem Cells (HESC) Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Human Embryonic Stem Cells (HESC) Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Human Embryonic Stem Cells (HESC) Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 42. North America Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Human Embryonic Stem Cells (HESC) Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 46. Europe Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 53. Asia-Pacific Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Human Embryonic Stem Cells (HESC) Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 65. Latin America Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 70. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Human Embryonic Stem Cells (HESC) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Human Embryonic Stem Cells (HESC) Value Chain
Figure 75. Human Embryonic Stem Cells (HESC) Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
